Brown Advisory
PCVX icon

Brown Advisory’s Vaxcyte PCVX Stock Holding History

Brown Advisory’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.7M Sell
511,701
-55,224
-10% -$3M 0.05% 267
2025
Q4 		$26.2M Sell
566,925
-110,060
-16% -$4.92M 0.04% 285
2025
Q3 		$24.4M Buy
676,985
+105,046
+18% +$3.48M 0.03% 295
2025
Q2 		$18.6M Buy
571,939
+1,681
+0.3% +$55.1K 0.02% 325
2025
Q1 		$21.5M Buy
570,258
+14,049
+3% +$1.12M 0.03% 306
2024
Q4 		$45.5M Buy
556,209
+112,170
+25% +$11.1M 0.06% 225
2024
Q3 		$50.7M Buy
444,039
+76,822
+21% +$6.92M 0.06% 219
2024
Q2 		$27.7M Buy
+367,217
New +$25M 0.04% 287

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return